Literature DB >> 16081775

Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells.

Thibault Griseri1, Lucie Beaudoin, Jan Novak, Lennart T Mars, Françoise Lepault, Roland Liblau, Agnès Lehuen.   

Abstract

Invariant NKT (iNKT) cells have been implicated in the regulation of autoimmune diseases. In several models of type 1 diabetes, increasing the number of iNKT cells prevents the development of disease. Because CD8 T cells play a crucial role in the pathogenesis of diabetes, we have investigated the influence of iNKT cells on diabetogenic CD8 T cells. In the present study, type 1 diabetes was induced by the transfer of CD8 T cells specific for the influenza virus hemagglutinin into recipient mice expressing the hemagglutinin Ag specifically in their beta pancreatic cells. In contrast to previous reports, high frequency of iNKT cells promoted severe insulitis and exacerbated diabetes. Analysis of diabetogenic CD8 T cells showed that iNKT cells enhance their activation, their expansion, and their differentiation into effector cells producing IFN-gamma. This first analysis of the influence of iNKT cells on diabetogenic CD8 T cells reveals that iNKT cells not only fail to regulate but in fact exacerbate the development of diabetes. Thus, iNKT cells can induce opposing effects dependent on the model of type 1 diabetes that is being studied. This prodiabetogenic capacity of iNKT cells should be taken into consideration when developing therapeutic approaches based on iNKT cell manipulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081775     DOI: 10.4049/jimmunol.175.4.2091

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells.

Authors:  Jan Novak; Lucie Novakova
Journal:  Clin Exp Med       Date:  2012-07-24       Impact factor: 3.984

Review 3.  The split personality of NKT cells in malignancy, autoimmune and allergic disorders.

Authors:  Jeff J Subleski; Qun Jiang; Jonathan M Weiss; Robert H Wiltrout
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

4.  Transient Depletion of Foxp3+ Regulatory T Cells Selectively Promotes Aggressive β Cell Autoimmunity in Genetically Susceptible DEREG Mice.

Authors:  Deepika Watts; Marthe Janßen; Mangesh Jaykar; Francesco Palmucci; Marc Weigelt; Cathleen Petzold; Angela Hommel; Tim Sparwasser; Ezio Bonifacio; Karsten Kretschmer
Journal:  Front Immunol       Date:  2021-08-10       Impact factor: 7.561

5.  Double negative (CD3+ 4- 8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes.

Authors:  Beverly Duncan; Cristina Nazarov-Stoica; Jacqueline Surls; Margaret Kehl; Constantin Bona; Sofia Casares; Teodor-D Brumeanu
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

6.  Invariant NKT Cell Lines Derived from the NOD·H2 Mouse Enhance Autoimmune Thyroiditis.

Authors:  Rajni B Sharma; Xiaoguang Fan; Patrizio Caturegli; Noel R Rose; C Lynne Burek
Journal:  J Thyroid Res       Date:  2011-04-10

Review 7.  CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.

Authors:  Yusuke Nishioka; Sakiko Masuda; Utano Tomaru; Akihiro Ishizu
Journal:  Front Immunol       Date:  2018-03-15       Impact factor: 7.561

8.  All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.

Authors:  Yang-Hau Van; Wen-Hui Lee; Serina Ortiz; Mi-Heon Lee; Han-Jun Qin; Chih-Pin Liu
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

Review 9.  Two to Tango: Dialogue between Adaptive and Innate Immunity in Type 1 Diabetes.

Authors:  Lin Sun; Shugang Xi; Guangyu He; Zhuo Li; Xiaokun Gang; Chenglin Sun; Weiying Guo; Guixia Wang
Journal:  J Diabetes Res       Date:  2020-07-30       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.